Paul Stockdale

Director of Finance/CFO at OXFORD BIODYNAMICS PLC

Net worth: 15 964 $ as of 2026-05-30

Health Technology

Consumer Services

Commercial Services

Profile

Paul Stockdale currently works at Oxford BioDynamics Plc, as Chief Financial Officer & Executive Director.
Mr. Stockdale also formerly worked at e-Therapeutics Plc, as Financial Controller from 2012 to 2017 and Deloitte & Touche LLP UK, as Senior Manager from 1996 to 2004.
Mr. Stockdale received his graduate degree from the University of Cambridge.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
OXFORD BIODYNAMICS PLC 0.15%	2025-11-09	6,411,252 ( 0.15% )	15 964 $	2026-05-30

Paul Stockdale active positions

Companies	Position	Start
OXFORD BIODYNAMICS PLC	Director of Finance/CFO	2017-09-14

All active positions of Paul Stockdale

Former positions of Paul Stockdale

Companies	Position	End
E-THERAPEUTICS PLC	Comptroller/Controller/Auditor	2017-08-31
Deloitte & Touche LLP UK Deloitte & Touche LLP UK Miscellaneous Commercial ServicesCommercial Services Provides financial advisory and accounting services	Corporate Officer/Principal	2003-12-31

See the detail of Paul Stockdale's experience

Training of Paul Stockdale

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Paul Stockdale's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
e-Therapeutics Plc e-Therapeutics Plc BiotechnologyHealth Technology Discovers and develops drugs	Health Technology
University of Cambridge University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Deloitte & Touche LLP UK Deloitte & Touche LLP UK Miscellaneous Commercial ServicesCommercial Services Provides financial advisory and accounting services	Commercial Services
Oxford BioDynamics Plc Oxford BioDynamics Plc BiotechnologyHealth Technology Discovers and develops novel biomarkers	Health Technology